| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000029165 |
| Receipt No. | R000033346 |
| Official scientific title of the study | Utility of nerve ultrasound in diabetic neuropathy |
| Date of disclosure of the study information | 2017/09/19 |
| Last modified on | 2019/01/07 (Ver. 6) |
| Basic information | ||
| Official scientific title of the study | Utility of nerve ultrasound in diabetic neuropathy | |
| Title of the study (Brief title) | Utility of nerve ultrasound in diabetic neuropathy | |
| Region |
|
|
| Condition | ||
| Condition | Diabetes | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The degree of nerve cross-sectional area increase in the continuation of hyperglycemia will be compared between diabetic patients group and healthy contorol group.In the diabetic patients group,study the relationship between nerve cross-sectional area and symptoms, tendon reflex, autonomic nerves function, HbA1c, duration of disease, vibration, tactile examination, nerve conduction study.
It is aimed to evaluate the relationship between nerve ultrasound and hyperglycemia and establish it as a new examination method suitable for early detection and follow - up of diabetic neuropathy. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Nerve cross-sectional area at each measurement point.
Median nerve in the wrist,forearm,elbow,upper arm. Tibial nerve in the behind the medial malleolus, popliteal. Sural nerve in the lower leg. Compare butween diabetic patients group and healthy contorol group. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | We will perform the nerve ultrasound examination. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Diabetic patients group
Patients who were hospitalized as diabetes education within the research period, who does not apply the exclusion criteria and obtained consent to the study. Healthy control group Staffs of Kochi Medical School who does not apply the exclusion criteria and obtained consent to the study,does not have impaired glucose tolerance. |
|||
| Key exclusion criteria | Patients who have a history of peripheral neuropathy due to a cause other than diabetes, or suffering from those diseases. | |||
| Target sample size | 50 | |||
| Research contact person | |
| Name of lead principal investigator | Yuna Yoshinaga |
| Organization | Kochi Medical School Hospital |
| Division name | Clinical Laboratory Department |
| Address | 185-1 Kohasu,Oko-cho,Nankoku-shi,Kochi 783-8505, JAPAN |
| TEL | 088-880-2427 |
| jm-yuna_0309@kochi-u.ac.jp | |
| Public contact | |
| Name of contact person | Yuna Yoshinaga |
| Organization | Kochi Medical School Hospital |
| Division name | Clinical Laboratory Department |
| Address | 185-1 Kohasu,Oko-cho,Nankoku-shi,Kochi 783-8505, JAPAN |
| TEL | 088-880-2427 |
| Homepage URL | |
| jm-yuna_0309@kochi-u.ac.jp | |
| Sponsor | |
| Institute | Kochi Medical School |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kochi Medical School |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033346 |